Insmed Incorporated

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.

CEO

William H. Lewis

CEOWilliam H. Lewis

Employees

1,271

Employees1,271

Headquarters

Bridgewater, New Jersey

HeadquartersBridgewater, New Jersey

Founded

1988

Founded1988

Employees

1,271

Employees1,271

INSM Key Statistics

Market cap

20.65B

Market cap20.65B

Price-Earnings ratio

-18.28

Price-Earnings ratio-18.28

Dividend yield

—

Dividend yield—

Average volume

2.20M

Average volume2.20M

High today

$108.89

High today$108.89

Low today

$105.75

Low today$105.75

Open price

$107.48

Open price$107.48

Volume

2.24M

Volume2.24M

52 Week high

$108.89

52 Week high$108.89

52 Week low

$60.40

52 Week low$60.40

Analyst ratings

100%

of 19 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Insmed Incorporated

Why Robinhood?

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. Show more

INSM Key Statistics

Analyst ratings

100%

People also own

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.